FDA fast-tracks first inhalable gene therapy for lung cancer
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
The FDA has granted fast-track status to a treatment for lung cancer. This treatment is described as an inhalable gene therapy, marking a first for this type of therapy. The fast-track designation is for a treatment intended for lung cancer.